Ipratropium Bromide Inhalation has 5 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acidifying Agents, Anticholinergic-Containing Drugs, Bromide. Patients taking Ipratropium Bromide Inhalation should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Major
- 3
- Moderate
- 2
Major (3)
- Ipratropium Bromide Inhalation + Acidifying Agents— Potential additive interaction with concomitantly used anticholinergic medications; coadministration should be avoided a…
- Ipratropium Bromide Inhalation + Anticholinergic-Containing Drugs— Avoid coadministration with other anticholinergic-containing drugs due to potential additive interaction that may lead t…
- Ipratropium Bromide Inhalation + Bromide— 7 DRUG INTERACTIONS Ipratropium bromide HFA inhalation aerosol has been used concomitantly with other drugs, including s…
Moderate (2)
- Ipratropium Bromide Inhalation + Albuterol— Concomitant use evaluated; formal studies exist but safety and effectiveness interaction not fully characterized with ot…
- Ipratropium Bromide Inhalation + Topical Steroids— Concomitant use documented in COPD treatment; no formal studies fully evaluating interaction effects with respect to saf…